The full picture of post-COVID-19 autoimmune diseases and their prevalence is lacking
despite numerous case reports and small series. Two studies that use large cohorts now …

ABSTRACT Introduction Post-COVID syndrome (PCS) is recognized as a new entity in the
context of SARS-CoV-2 infection. Though its pathogenesis is not completely understood …

SARS-CoV-2 infection for most children results in mild or minimal symptoms, though in rare
cases severe disease can develop, including a multisystem inflammatory syndrome (MIS-C) …

Abstract Objectives Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2, has
opened a new era in the practice of pediatric rheumatology since it has been associated …

Objective To review whether the current COVID-19 vaccines can prevent the occurrence of
multisystem inflammatory syndrome in children (MIS-C) and adolescents. Methods A …

Abstract Purpose of Review Since it first appeared, multisystem inflammatory syndrome in
children (MIS-C) associated with coronavirus disease 2019 (COVID-19) has been compared …

In the beginning of COVID-19, the proportion of confirmed cases in the pediatric population
was relatively small and there was an opinion that children often had a mild or asymptomatic …

Microbiota composition may play a role in the development, prognosis, or post-infection of
COVID-19. There are studies evaluating the microbiota composition at the time of diagnosis …

Background Multisystem inflammatory syndrome in children (MIS-C) is a novel disease that
was identified during the COVID-19 pandemic and is characterised by systemic …

The clinical and immunological spectrum of acute and post-active COVID-19 syndrome
overlaps with criteria used to characterize autoimmune diseases such as rheumatoid …